Skip to content

Altimmune ALT Operating margin

Operating margin at other companies

Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
-27.7%-12.2pp
Wave Life Sciences logo
Wave Life SciencesWVE
-75.7%-33.6pp
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-597.9%-207pp
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-15,536.1%-17,275pp
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-139.8%-168pp
Alumis Inc. logo
Alumis Inc.ALMS
-5,364%

Other financials

Income statement

See full
Revenue$26.0K+420%
Operating income-$24.2M-11.1%
Net income-$22.6M-15.3%
EPS (diluted)-$0.18+30.8%

Balance sheet

See full
Cash & equivalents$97.6M+98.7%
Total debt$34.8M+14,092%
Total equity$284.0M+99.8%
Total assets$335.6M+113%

Cash flow

See full
Operating cash flow-$20.9M-24.4%
CapEx$21.0K
Free cash flow-$21.0M

Valuation

See full
Market cap$558.14M-2.1%
Enterprise value$495.27M-5.0%
P/S13,613.2×-24,380×

Profitability

See full
Net margin-214,861%-76,057pp
FCF margin-17,806.8%-110,030pp

Returns & leverage

See full
Return on equity-42.7%-8.7pp
Debt / equity0.1×+0.1×
Current ratio29.6×+13.7×

Where this comes from

Calculated from Altimmune’s reported figures.

Based on trailing twelve months.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Altimmune's operating margin?
Altimmune (ALT) reported operating margin of -230,461% in Q4 2025.
How has Altimmune's operating margin changed year-over-year?
Altimmune's operating margin increased by 55.3% year-over-year, from -515,860% to -230,461%.
What is the long-term trend for Altimmune's operating margin?
Over 5 years (2020 to 2025), Altimmune's operating margin has grown at a 221.6% compound annual growth rate (CAGR), from -669.5% to -230,461%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.